LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today revealed new ...

Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

Havas is forging deeper into the GLP-1 space with a series of YouTube videos about the drug class and its impact on the world ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

The evolution of AI, more limited-time product offerings and GLP-1 use for weight loss are among the issues expected to play ...

British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...

In a notable move, Hims & Hers Health donated $1 million to President-elect Donald Trump’s inauguration fund, signaling its ...